.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Baxter
Cantor Fitzgerald
Deloitte
Johnson and Johnson
Citi
Queensland Health
Mallinckrodt
Julphar
QuintilesIMS

Generated: December 13, 2017

DrugPatentWatch Database Preview

APOKYN Drug Profile

« Back to Dashboard

Which patents cover Apokyn, and when can generic versions of Apokyn launch?

Apokyn is a drug marketed by Us Worldmeds and is included in one NDA.

The generic ingredient in APOKYN is apomorphine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apomorphine hydrochloride profile page.
Drug patent expirations by year for APOKYN

Pharmacology for APOKYN

Drug ClassDopaminergic Agonist
Mechanism of ActionDopamine Agonists

Medical Subject Heading (MeSH) Categories for APOKYN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Us WorldmedsAPOKYNapomorphine hydrochlorideINJECTABLE;SUBCUTANEOUS021264-001Apr 20, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Us WorldmedsAPOKYNapomorphine hydrochlorideINJECTABLE;SUBCUTANEOUS021264-002Apr 20, 2004RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
McKesson
Chinese Patent Office
Deloitte
Moodys
McKinsey
Colorcon
Federal Trade Commission
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot